Mateusz Kaczmarek, Author at TechStock²

Adtalem (ATGE) Stock Plummets 27% After Earnings – Latest News, Key Facts & Expert Outlook

Q1 Earnings Highlights and Stock Reaction Robust Q1 FY2026 Results: Adtalem’s earnings for the quarter ended Sept 30, 2025 impressed on many fronts. Revenue came in at $462.3 million, up 10.8% year-over-yearbusinesswire.com, while adjusted net income rose to $64.9 million (from $50.5M)businesswire.com. Adjusted earnings were $1.75 per share, a 35.7% YoY jumpbusinesswire.com, handily beating the consensus estimate of ~$1.57. GAAP EPS was $1.67 vs $1.18 in the prior-year quarterbusinesswire.com. Importantly, enrollments continued to climb, with total student enrollment up 8.0% from last yearbusinesswire.com – marking Adtalem’s ninth straight quarter of growth, a rare streak in the education industry. The Chamberlain

31 October 2025

Earnings Reports·NYSE:ATGE·Stock Market

AI Goldmine or Next Bubble? Inside Credo (CRDO) Stock’s 1300% Surge and Future Outlook

Latest Stock Price and Momentum Credo (NASDAQ: CRDO) has been on a tear in late 2025, with its stock price around $188 as of October 31, 2025. This represents a ~12% jump in one day and extends a powerful rally that saw shares touch new highs. Just yesterday the stock hit $179.13 intraday, a 52-week peak. Notably, Credo’s stock closed 2024 near the $60–$70 range; it has since nearly tripled in 2025 amid feverish interest in AI-related tech companies. Year-to-date, CRDO is up roughly +180%, and over the past 12 months it has climbed about +350% – an exceptional run

31 October 2025

AI Stocks·NASDAQ:CRDO

Datavault AI (DVLT) Skyrockets 800% on Bitcoin Deal and IBM Partnership – Can the AI Stock Rally Last?

Company Overview & Stock Performance Datavault AI Inc. (NASDAQ: DVLT) is a micro-cap tech company that specializes in turning data into a valuable asset. The firm’s cloud-based platform uses AI and blockchain to visualize, value, and monetize data across industriesir.datavaultsite.com. (For example, Datavault enables creation of “digital twins” of real-world assets and secure data exchanges to trade information.) Originally a wireless audio tech company, DVLT rebranded and pivoted to the Web3 data monetization space, riding the wave of investor enthusiasm for anything AI-related. This year, Datavault’s stock has been on a roller-coaster rally. In late September 2025, DVLT was a

31 October 2025

Artificial Intelligence·Cryptocurrency·NASDAQ:DVLT·Stock Market

Illumina Stock Surges on Genomics Breakthroughs – What’s Next for ILMN?

Q3 2025 Earnings: Beat Expectations and Lifted Guidance Illumina’s latest quarterly report (Q3 FY2025) provided a much-needed spark for investors. The San Diego-based genomics giant reported $1.084 billion in revenue for Q3, slightly above Wall Street estimates (~$1.07B) and flat versus the same quarter last yearinvesting.com. While flat growth might not sound impressive, it exceeded Illumina’s own guidance range, marking an improvement in a year where demand had been soft. Adjusted earnings were $1.34 per share, handily beating the ~$1.17 consensusinvesting.com. CEO Jacob Thaysen noted the team “delivered Q3 results that exceeded the high-end of our guidance… driven by revenue acceleration

31 October 2025

Biotechnology·Stock Market

Cloudflare (NET) Stock Soars to Record High on Earnings and AI Buzz – What’s Next for Investors?

Stock Performance and Recent Trends Cloudflare’s stock price has been on a tear in 2025, recently hitting an all-time high around $230 per sharewatcher.guru. After a rally into its Q3 earnings announcement, the stock closed October 30 at $222.94 (down ~1.9% that day after profit-taking)ts2.tech, then spiked in after-hours trading once results beat expectationsts2.tech. As of October 31, 2025, NET trades in the mid-$220s – roughly 95–100% higher than where it started the yearts2.tech. For context, the Nasdaq-100 is up only ~40% YTD, so Cloudflare has dramatically outpaced the broader market. Investors have rewarded the company for consistent growth and

31 October 2025

Artificial Intelligence·Earnings Reports·Stock Market

Palantir’s $400 Billion AI Juggernaut: Inside PLTR’s 2025 Surge, Deals & Future Forecasts

Current Stock Performance: 2025’s Outperformer Palantir’s stock performance in 2025 has been nothing short of extraordinary. The share price has more than quadrupled this year, making Palantir one of the top-performing stocks on the marketts2.tech. After starting the year at roughly $45, PLTR rocketed to new records by late October – touching an intraday high around $190 and closing at an all-time high near $189ts2.tech. This surge translates to about a +300% year-to-date gain in 2025ts2.tech, vastly outpacing the broader indices. By comparison, the Nasdaq Composite is up only modestly and even other “AI winner” stocks (like Nvidia or Microsoft)

31 October 2025

Artificial Intelligence·NYSE:PLTR·Stock Market

Arbor Realty Trust’s 12% Dividend: Golden Opportunity or Yield Trap in 2025?

1. Company Overview Arbor Realty Trust, Inc. is a specialized real estate finance company operating as an externally-managed REIT. Founded in 2003 and headquartered in Uniondale, NY, Arbor’s business is centered on originating, investing in, and servicing real estate loans – primarily in the multifamily housing sector (apartment complexes and single-family rental portfolios) as well as various commercial real estate assetsstocktitan.net. The company’s integrated platform provides bridge loans, mezzanine financing, preferred equity, and other structured finance products on its balance sheet, while also acting as a major agency loan originator selling to government-sponsored entities. Arbor’s dual business segments are: Business

31 October 2025

Dividend Stocks·Financial Planning·NYSE:ABR

Luminar’s LiDAR Rollercoaster: LAZR Stock Soars on Buyout Buzz, Crashes on Cash Crunch – October 2025 Update

Latest News: Buyout Buzz vs. Cash Crunch Late October brought whiplash for Luminar investors. On Oct. 25, 2025, Luminar’s stock skyrocketed ~31% in a single session, hitting an intraday high around $2.28ts2.techts2.tech. This surge was fueled by two factors: a broad tech rally (markets jumped on cooling inflation and AI optimism) and speculation about a buyout led by Luminar’s founder. Media reports and an SEC filing revealed that Austin Russell – Luminar’s 28-year-old founder who was ousted as CEO in May – had proposed a deal to acquire all outstanding Class A shares through his new venture, Russell AI Labsts2.tech. The

31 October 2025

Company Updates·NASDAQ:LAZR·Stock Market·Tech News

Robinhood’s Wild 2025 Ride: HOOD Stock Skyrockets 250% Amid Crypto Boom, New Gambits & Big Risks

Overview of Robinhood Markets, Inc. Founded in 2013 with a mission to make investing accessible, Robinhood has grown into one of the most widely used retail trading platforms in the U.S. The app’s gamified, user-friendly interface – with instant account setup and free trades – brought a new generation into the stock market. By mid-2025, Robinhood reported 26.5 million funded accounts on its platformts2.tech. For context, that user base rivals the largest traditional brokers: Charles Schwab, after its TD Ameritrade acquisition, has ~38 million active brokerage accountspressroom.aboutschwab.com. Unlike those full-service brokers, Robinhood does not offer personalized financial advice, but it

31 October 2025

Cryptocurrency·Risk Management·Stock Market

DexCom Stock Plunge Raises Big Questions – Will This Diabetes Tech Leader Rebound?

Latest News: Earnings Beat Marred by Growth Jitters DexCom’s Q3 2025 earnings (reported Oct. 30) were better than expected, but the celebration was short-lived. The headline numbers were strong – $1.209 B revenue (+22% YoY) and $0.61 adjusted EPS – beating consensus on bothinvesting.com. In fact, demand for DexCom’s G7 continuous glucose monitors (CGMs) drove 20% organic growth globally, with U.S. sales up 21% and international up 18% YoYinvesting.com. Off the back of this strength, management raised full-year 2025 guidance, now targeting ~$4.63 B revenue (~15% growth)investors.dexcom.com and improved operating margins around 20–21%. However, on the earnings call DexCom’s interim CEO Jake

31 October 2025

Stock Market

Astera Labs Stock Skyrockets on AI Buzz and Photonics Deal – Can ALAB Keep Climbing?

Astera Labs Stock Price & Recent Movement (October 2025) Astera Labs’ stock has been on a roller coaster in recent weeks. After skyrocketing through mid-2025 on AI frenzy, ALAB shares peaked at an all-time high of $262.90 on September 18, 2025ts2.tech. A broad tech sell-off and profit-taking then set in: by early October, Astera had pulled back to the mid-$190sts2.tech. Volatility spiked mid-month – on October 14–15, the stock plunged from ~$200 to the low-$160s, a nearly 19% two-day dropts2.tech. The immediate trigger was AMD’s October 14 announcement of a 50,000-GPU deal with Oracle, which stoked fears that proprietary GPU-cloud

31 October 2025

Artificial Intelligence·NASDAQ:ALAB·Stock Market

Newell Brands Stock Crashes on Tariff Woes – Inside NWL’s Plunge and Turnaround Struggles

In-Depth Report Stock Price Plunge and Recent Performance Newell Brands’ stock cratered in late October 2025, culminating in a one-day collapse on October 31 after its earnings release. The shares fell from about $4.72 to around $3.25 in a single session, a drop of roughly 32%tokenist.com. This rout left the stock at its lowest price on recordtokenist.com, an astonishing fall for a company that five years ago traded above $20 per share. The selloff on Oct. 31 was precipitated by disappointing quarterly results and a hefty cut to the company’s outlook (more on that below). It capped off a brutal

31 October 2025

NASDAQ:NWL·Stock Market

Previous 1 … 86 87 88 89 90 … 233 Next

Pfizer stock price rises into weekend as FDA priority review, TrumpRx discounts grab focus

7 February 2026

Pfizer shares rose 2.8% to $27.22 Friday after the FDA granted priority review for a Hympavzi label expansion, with a decision expected in Q2 2026. Trading volume reached 50.7 million shares. The TrumpRx.gov drug-discount rollout put renewed focus on pricing, with over 30 Pfizer drugs listed at launch.

Bitfarms stock jumps on Keel rebrand and U.S. redomiciliation plan — what BITF investors watch next

7 February 2026

Bitfarms shares jumped 25.2% to $2.14 Friday after the company announced plans to move its legal home to the U.S. and rebrand as Keel Infrastructure, pending a March 20 shareholder vote. The company also said it will repay its $100 million Macquarie debt facility and reported $698 million in net liquidity.

CoreWeave stock jumps 20% as CRWV heads into Feb. 26 earnings — what traders watch next

7 February 2026

CoreWeave shares surged 20.5% to $89.95 Friday, capping a volatile week for AI stocks. The company launched its ARENA lab and a new ad campaign, and set Feb. 26 for its earnings release. SVP Chen Goldberg sold nearly 18,000 shares for tax withholding. A securities class action lawsuit was filed covering trades from March 28 to Dec. 15, 2025.

Arista Networks (ANET) stock jumps into the weekend — here’s what traders watch next week

7 February 2026

Arista Networks shares jumped 6.85% to $137.49 Friday, breaking a two-day slide on volume of about 9 million shares, above average. The move came ahead of Arista’s earnings set for Feb. 12 and U.S. CPI data on Feb. 13. Options pricing signals traders expect volatility around the results. The Dow closed above 50,000 for the first time.

Mateusz Kaczmarek

Stock Market Today